Clinical trial · Observational
Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13). The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumor | Solid Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To assess the Vulnerable Elders Survey score (VES-13)
- timeFrame
- Within 3 months after recruitment
- description
- A patient is identified vulnerable if the score is ≥ 3
Secondary outcomes (2)
- measure
- To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert
- timeFrame
- Within 3 months after recruitment
- description
- A patient will be identified as vulnerable if he/she belongs to the "intermediate" or "frail" category. The Kappa coefficient of agreement will be used to correlate the VES-13 score and clinical observations.
- measure
- To measure the muscle strength using the grip strength test
- timeFrame
- Within 3 months after recruitment
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * patient aged ≥ 70 * coming for a first visit, whatever the purpose and the disease stage Exclusion Criteria: * neglect or refusal to answer to the VES-13 test
References
Publications (0)
Data not yet available